sufficient information is available to clinicians and patients on the overall level of activity of antineoplastic drugs in ovarian cancer and their potential for improving patients' outcomes.boxed ...

ASCO-ONS standards for the administration of antineoplastic therapy provide a framework for ensuring patient safety.

Azacitidine (Vidaza, Pharmion Corporation, Boulder, CO), an injectable antineoplastic agent, is the first drug in a new class of compounds, known as DNA hypomethylating agents, to receive FDA ...